Rose Bengal clinical trials
Includes 6 studies of Rose bengal sodium.
How each study uses Rose Bengal is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 3
Provectus Biopharmaceuticals, Inc. (4) · Provectus Pharmaceuticals (3) · University of California, San Francisco (2) · King Saud University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Studies
Open first, then newest update. How each study uses Rose Bengal is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- Rose Bengal Electromagnetic Activation With Green Light for Infection ReductionCompletedPhase 3University of California, San FranciscoNCT05110001Written as Rose Bengal
- Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction IIActive, not recruitingPhase 3University of California, San FranciscoNCT06271772Written as Rose Bengal
- PV-10 in Combination With Pembrolizumab for Treatment of Metastatic MelanomaActive, not recruitingPhase 1/2Provectus Biopharmaceuticals, Inc.NCT02557321Written as PV-10
- A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the LiverStatus unknownPhase 1Provectus Biopharmaceuticals, Inc.NCT02693067Written as Rose bengal disodium
- A Study to Assess PV-10 Chemoablation of Cancer of the LiverStatus unknownPhase 1Provectus Biopharmaceuticals, Inc.NCT00986661Written as PV-10 (10% rose bengal disodium)
- PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous MelanomaTerminatedPhase 3Provectus Biopharmaceuticals, Inc.NCT02288897Written as PV-10 (10% rose bengal disodium)
- Curcumin; Rose Bengal; Denture StomatitisStatus unknownPhase 3King Saud UniversityNCT04837664Written as Rose Bengal
- A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10CompletedPhase 2Provectus PharmaceuticalsNCT02322086Written as Topical Rose Bengal, 0.005%
- Phase 2 Study of Intralesional PV-10 for Metastatic MelanomaCompletedPhase 2Provectus PharmaceuticalsNCT00521053Written as PV-10 (10% rose bengal disodium)
- Intralesional PV-10 Chemoablation of Metastatic MelanomaCompletedPhase 1Provectus PharmaceuticalsNCT00219843Written as PV-10 (rose bengal disodium, 10%)
Codes
What other systems call Rose Bengal · ClinicalTrials.gg INT008168
- MeSH (NLM) D012395Rose BengalConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 1ZPG1ELY14ROSE BENGAL POTASSIUMConfirmed FDA, NLM, Wikidata
- RxNorm 9471Confirmed FDA, Wikidata
- Wikidata Q27887647rose bengal potassiumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C223450Rose Bengal PotassiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012395 | Rose Bengal | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 1ZPG1ELY14 | ROSE BENGAL POTASSIUM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 9471 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27887647 | rose bengal potassium | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C223450 | Rose Bengal Potassium | One source FDA |
Also registered as rose bengal sodium i-125 (UNII 31S841PMN7) and rose bengal sodium i-131 (UNII 24I7KUI7MK · RxNorm 82097).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.